CHANJET (01588): Re-elect Yang Yuchun as Executive Director
Changtian Technology (01588) announced that the re-election of the following individuals as directors of the sixth board of directors has been formally approved by shareholders at the extraordinary general meeting, with a term of three years starting from the date of the extraordinary general meeting: (i) the re-election of Mr. Wang Wenjing and Mr. Wu Zhengping as non-executive directors of the sixth board of directors; (ii) the re-election of Mr. Yang Yuchun as an executive director of the sixth board of directors; and (iii) the re-election of Mr. Liu Junhui, Ms. Wu Xiaoqing, and Mr. Cui Qiang as independent non-executive directors of the sixth board of directors.
CHANJET (01588) announced that the re-election of the following individuals to the sixth board of directors has been formally approved by shareholders at the extraordinary general meeting, with a term of three years starting from the date of the extraordinary general meeting: (i) the re-election of Mr. Wang Wenjing and Mr. Wu Zhengping as non-executive directors of the sixth board of directors; (ii) the re-election of Mr. Yang Yuchun as an executive director of the sixth board of directors; and (iii) the re-election of Mr. Liu Junhui, Ms. Wu Xiaoqing, and Mr. Cui Qiang as independent non-executive directors of the sixth board of directors.
The re-election of the following individuals to the sixth supervisory board has been formally approved by shareholders at the extraordinary general meeting, with a term of three years starting from the date of the extraordinary general meeting: (i) the re-election of Mr. Guo Xinping and Mr. Li Weimin as shareholder representative supervisors of the sixth supervisory board; and (ii) the re-election of Mr. Ruan Guangli and Mr. Ma Yongyi as independent supervisors of the sixth supervisory board.
Related Articles

BOAN BIOTECH (06955) repurchased 1.5 million shares at a cost of approximately HKD 4.5537 million on September 8.

CICC (03908) plans to issue company bonds of no more than 6 billion yuan.

C-MER MEDICAL (03309) spent approximately HKD 170,200 to repurchase 200,000 shares on September 8.
BOAN BIOTECH (06955) repurchased 1.5 million shares at a cost of approximately HKD 4.5537 million on September 8.

CICC (03908) plans to issue company bonds of no more than 6 billion yuan.

C-MER MEDICAL (03309) spent approximately HKD 170,200 to repurchase 200,000 shares on September 8.

RECOMMEND





